Advanced Medical Isotope Corporation has added Thomas J. Clement, to the Board of Directors. Tom Clement has recently held the positions of Chairman of the Washington State Biotechnology and Biomed Association (WBBA) as well as the Director of New Ventures-Life Sciences for the University of Washington's Center for Commercialization. Tom is currently the CEO of two start-up companies, Cardiac Insight Inc., and Aqueduct Neurosciences Inc. and is on the Board of Directors of several medical technology companies.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.172 USD | -6.57% | -14.00% | +137.90% |
May. 09 | Vivos Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 18 | Vivos Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+137.90% | 71.78M | |
-3.61% | 14.99B | |
-38.48% | 2.82B | |
-11.54% | 2.5B | |
-14.52% | 1.42B | |
-.--% | 1.12B | |
+54.63% | 568M | |
+89.23% | 497M | |
+23.36% | 261M | |
-1.29% | 230M |
- Stock Market
- Equities
- RDGL Stock
- News Vivos Inc.
- Advanced Medical Isotope Corporation Appoints Thomas J. Clement to its Board of Directors